Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyproheptadine in pulmonary arterial hypertension
IRCT20130921014727N7Phase 4Completed
- Sponsor
- Faculty of Pharmacy, Shahid Beheshti University of Medical Sciences
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in pulmonary arterial hypertension (PAH) comparing Cyproheptadine with Placebo (2 arms). Primary endpoints: 6-minute walk distance, Mean pulmonary arterial pressure and 2 more. Started Jan 2015; status: completed.
02
Drugs
cyproheptadine
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on IRCT20130921014727N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130921014727N7.